rp-1,nivolumab,rp2
bms,replimune
['rp1', 'ignyte', 'melanoma', 'rp2 ', 'replimune']
replimune presents rp1 data from the ignyte anti-pd1 failed melanoma cohort and rp2 data in uveal melanoma at the 2023 american society of clinical oncology (asco) annual meeting #stocksoftheday #stockalert #stocknews #event #newclinicaltrialdata #skin 
Find the most important news and press releases about U.S. publicly-traded companies in real-time and stay ahead of the game!